Date of Presentation
5-5-2022 12:00 AM
College
School of Osteopathic Medicine
Poster Abstract
Hypercoagulable disorders are often the culprit for repeated strokes in young patients, with or without other comorbidities
Medications typically used for stroke prophylaxis:
- Warfarin
- Aspirin
- Direct Oral Anticoagulants (DOACs)
Warfarin is the preferred method of anticoagulation for stroke prophylaxis in patients with hypercoagulable disorders
A deficiency of protein S increases the risk of pro coagulation due to a relative deficiency of anticoagulants.
Patients with protein S deficiency tend to have recurrent venous thromboses and pulmonary emboli
Keywords
Blood Coagulation Disorders, Anticoagulants, Protein S, Protein S Deficiency, Stroke, Factor Xa Inhibitors, Case Reports
Disciplines
Cardiology | Cardiovascular Diseases | Chemicals and Drugs | Hematology | Medicine and Health Sciences | Neurology
Document Type
Poster
Included in
Cardiology Commons, Cardiovascular Diseases Commons, Chemicals and Drugs Commons, Hematology Commons, Neurology Commons
Stroke in HFrEF Without Atrial Fibrillation and Concurrent Protein S Deficiency: What Is the Best Treatment?
Hypercoagulable disorders are often the culprit for repeated strokes in young patients, with or without other comorbidities
Medications typically used for stroke prophylaxis:
- Warfarin
- Aspirin
- Direct Oral Anticoagulants (DOACs)
Warfarin is the preferred method of anticoagulation for stroke prophylaxis in patients with hypercoagulable disorders
A deficiency of protein S increases the risk of pro coagulation due to a relative deficiency of anticoagulants.
Patients with protein S deficiency tend to have recurrent venous thromboses and pulmonary emboli